The DART Study- Daratumumab Treatment in ITP
NCT04703621
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
21
Enrollment
OTHER
Sponsor class
Conditions
ITP
Interventions
DRUG:
Daratumumab Injection
Sponsor
Ostfold Hospital Trust
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]